Cosmo Pharmaceuticals N.V. (FRA:C43)
Germany
· Delayed Price · Currency is EUR 98.50
+5.00 (5.35%)
At close: Dec 5, 2025
Cosmo Pharmaceuticals Revenue
Cosmo Pharmaceuticals had revenue of 51.72M EUR in the half year ending June 30, 2025, with 18.46% growth. This brings the company's revenue in the last twelve months to 182.27M, down -1.66% year-over-year. In the year 2024, Cosmo Pharmaceuticals had annual revenue of 266.79M with 187.55% growth.
Revenue (ttm)
182.27M
Revenue Growth
-1.66%
P/S Ratio
8.53
Revenue / Employee
549.01K
Employees
322
Market Cap
1.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 266.79M | 174.01M | 187.55% |
| Dec 31, 2023 | 92.78M | -9.31M | -9.12% |
| Dec 31, 2022 | 102.09M | 37.02M | 56.88% |
| Dec 31, 2021 | 65.07M | 4.13M | 6.77% |
| Dec 31, 2020 | 60.95M | -1.55M | -2.47% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |